As of 2025-09-19, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (18.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.82 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -247.2%.
The range of the Relative Valuation is (20.75) - (22.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.1x - 32.2x | 27.5x |
| Forward P/E multiples | 16.9x - 27.9x | 19.9x |
| Fair Price | (20.75) - (22.21) | (18.87) |
| Upside | -261.8% - -273.3% | -247.2% |
| Date | P/E |
| 2025-09-16 | -16.22 |
| 2025-09-15 | -16.43 |
| 2025-09-12 | -15.84 |
| 2025-09-11 | -16.94 |
| 2025-09-10 | -15.60 |
| 2025-09-09 | -15.84 |
| 2025-09-08 | -15.75 |
| 2025-09-05 | -16.14 |
| 2025-09-04 | -16.35 |
| 2025-09-03 | -16.14 |
| 2025-09-02 | -16.13 |
| 2025-08-29 | -16.55 |
| 2025-08-28 | -16.72 |
| 2025-08-27 | -16.29 |
| 2025-08-26 | -16.08 |
| 2025-08-25 | -15.91 |
| 2025-08-22 | -16.33 |
| 2025-08-21 | -15.86 |
| 2025-08-20 | -15.44 |
| 2025-08-19 | -15.78 |
| 2025-08-18 | -15.59 |
| 2025-08-15 | -16.38 |
| 2025-08-14 | -16.23 |
| 2025-08-13 | -16.33 |
| 2025-08-12 | -15.90 |
| 2025-08-11 | -15.26 |
| 2025-08-08 | -15.32 |
| 2025-08-07 | -15.75 |
| 2025-08-06 | -14.68 |
| 2025-08-05 | -13.88 |
| 2025-08-04 | -13.70 |
| 2025-08-01 | -12.98 |
| 2025-07-31 | -12.86 |
| 2025-07-30 | -13.11 |
| 2025-07-29 | -13.05 |
| 2025-07-28 | -13.33 |
| 2025-07-25 | -13.50 |
| 2025-07-24 | -13.39 |
| 2025-07-23 | -13.65 |
| 2025-07-22 | -13.23 |
| 2025-07-21 | -12.95 |
| 2025-07-18 | -13.05 |
| 2025-07-17 | -13.19 |
| 2025-07-16 | -13.60 |
| 2025-07-15 | -13.89 |
| 2025-07-14 | -14.51 |
| 2025-07-11 | -14.85 |
| 2025-07-10 | -15.17 |
| 2025-07-09 | -14.98 |
| 2025-07-08 | -14.75 |